Monthly Binge Drinking Triples Liver Damage Risk

New US research reveals that even one heavy drinking session per month could triple the risk of severe liver scarring in people with metabolic liver disease, affecting one in three UK adults.

Obesity Pill Revolution: Daily Tablet Challenges Injections

A new daily obesity pill, Foundavo, gains FDA approval in the U.S., with Britain likely to follow. This oral alternative to weekly GLP-1 injections could transform weight loss treatment, offering convenience and potentially lower costs amid rising demand.

Page 20 of 880
Pickt mobile sticky banner — logo, tagline and CTA button